Science Explorer Interactive view Map
Company · Groningen · Netherlands

Ophtec (Netherlands)

ophtec.comROR OpenAlex
Research works
4
▼ 45% vs 2013–17
Citations
31
7.8 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
42%
world 28%

Not ranked overall: Ophtec (Netherlands) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does Ophtec (Netherlands) publish most on?

By volume in 2022–2025: Proteoglycans and glycosaminoglycans research, Advanced Drug Delivery Systems and Glycosylation and Glycoproteins Research.

Proteoglycans and glycos…0Proteoglycans and glycosaminoglycans research: 0 fractional worksAdvanced Drug Delivery S…0Advanced Drug Delivery Systems: 0 fractional worksGlycosylation and Glycop…0Glycosylation and Glycoproteins Research: 0 fractional works
Cell BiologyPharmaceutical ScienceMolecular Biology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Proteoglycans and glycosaminoglycans research Cell Biology 0 works
  2. 2 Advanced Drug Delivery Systems Pharmaceutical Science 0 works
  3. 3 Glycosylation and Glycoproteins Research Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available41.7%not open58.3%

World: 28% of research is openly available.

with international co-authors75.0%domestic only25.0%

World: 19% is written across borders.

How has Ophtec (Netherlands)'s research output changed?

Output in 2018–2022 was 45% lower than in 2013–2017.

20102015
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Groningen

All research institutions in Groningen

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.